Candesartan Cilexetil
C33H34N6O6
610.67
1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester, (±);
(±)-1-Hydroxyethyl 2-ethoxy-1-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester);
1-Cyclohexyloxycarbonyloxyethyl 2-ethoxy-1-{[2’-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}benzimidazole-7-carboxylate [145040-37-5]
1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester, (±);
(±)-1-Hydroxyethyl 2-ethoxy-1-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester);
1-Cyclohexyloxycarbonyloxyethyl 2-ethoxy-1-{[2’-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}benzimidazole-7-carboxylate [145040-37-5]
DEFINITION
Candesartan Cilexetil contains NLT 98.0% and NMT 102.0% of candesartan cilexetil (C33H34N6O6), calculated on anhydrous basis.
USP REFERENCE STANDARDS FOR PURCHASE
USP Candesartan Cilexetil RSUSP Candesartan Cilexetil Related Compound A RS
USP Candesartan Cilexetil Related Compound B RS
USP Candesartan Cilexetil Related Compound D RS
USP Candesartan Cilexetil Related Compound F RS
USP Candesartan Cilexetil Related Compound G RS